Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acotiamide
2. N-(2-(diisopropylamino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-1,3-thiazole-4-carboxamide
3. N-(n',n'-diisopropylaminoethyl)-(2-(2-hydroxy-4,5-dimethoxybenzoylamino)-1,3-thiazole-4-yl)carboxyamide
4. Ym 443
5. Ym-443
6. Ym443 Cpd
7. Z 338
8. Z-338
1. 185104-11-4
2. Acotiamide Hcl
3. Acotiamide (hydrochloride)
4. Z338
5. N-[2-[di(propan-2-yl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxamide;hydrochloride
6. Mfcd23103502
7. 510791nn30
8. Ym 443
9. 4-thiazolecarboxamide, N-(2-(bis(1-methylethyl)amino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-, Monohydrochloride
10. N-[2-(diisopropylamino)ethyl]-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxamide Hydrochloride
11. Unii-510791nn30
12. N-(2-(diisopropylamino)ethyl)-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxamide Hydrochloride
13. Acotiamidehydrochloride
14. Z-338 Dihydrochloride
15. Acotiamide Dihydrochloride
16. Z 338
17. Schembl6968566
18. Dtxsid30171717
19. Acotiamide Hydrochloride [mi]
20. Akos030529148
21. Hy-121467a
22. Sb19647
23. Acotiamide Hydrochloride [who-dd]
24. Acotiamide Hydrochloride Anhydrous
25. Ds-19577
26. N-(n',n'-diisopropylaminoethyl)-(2-(2-hydroxy-4,5-dimethoxybenzoylamino)-1,3-thiazole-4-yl)carboxyamide
27. N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxamide Hydrochloride
28. Sy226332
29. Acotiamide Dihydrochloride, >=98% (hplc)
30. Cs-0103547
31. F14757
32. J-011862
33. Q27260838
34. 4-thiazolecarboxamide, N-(2-(bis(1-methylethyl)amino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-, Hydrochloride (1:1)
35. N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxamide
1. Acofide
2. Acotiamide Hydrochloride Hydrate
Molecular Weight | 487.0 g/mol |
---|---|
Molecular Formula | C21H31ClN4O5S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 10 |
Exact Mass | 486.1703690 g/mol |
Monoisotopic Mass | 486.1703690 g/mol |
Topological Polar Surface Area | 141 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 586 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Cholinesterase Inhibitors
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32458
Submission : 2018-01-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20144
Submission : 2007-01-12
Status : Inactive
Type : II
Date of Issue : 2021-01-08
Valid Till : 2023-06-17
Written Confirmation Number : WC-0474A2
Address of the Firm :
Date of Issue : 2022-06-07
Valid Till : 2025-06-16
Written Confirmation Number : WC-0049
Address of the Firm :
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Acotiamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acotiamide, including repackagers and relabelers. The FDA regulates Acotiamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acotiamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Acotiamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Acotiamide supplier is an individual or a company that provides Acotiamide active pharmaceutical ingredient (API) or Acotiamide finished formulations upon request. The Acotiamide suppliers may include Acotiamide API manufacturers, exporters, distributors and traders.
click here to find a list of Acotiamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Acotiamide DMF (Drug Master File) is a document detailing the whole manufacturing process of Acotiamide active pharmaceutical ingredient (API) in detail. Different forms of Acotiamide DMFs exist exist since differing nations have different regulations, such as Acotiamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Acotiamide DMF submitted to regulatory agencies in the US is known as a USDMF. Acotiamide USDMF includes data on Acotiamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Acotiamide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Acotiamide suppliers with USDMF on PharmaCompass.
A Acotiamide written confirmation (Acotiamide WC) is an official document issued by a regulatory agency to a Acotiamide manufacturer, verifying that the manufacturing facility of a Acotiamide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Acotiamide APIs or Acotiamide finished pharmaceutical products to another nation, regulatory agencies frequently require a Acotiamide WC (written confirmation) as part of the regulatory process.
click here to find a list of Acotiamide suppliers with Written Confirmation (WC) on PharmaCompass.
Acotiamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acotiamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acotiamide GMP manufacturer or Acotiamide GMP API supplier for your needs.
A Acotiamide CoA (Certificate of Analysis) is a formal document that attests to Acotiamide's compliance with Acotiamide specifications and serves as a tool for batch-level quality control.
Acotiamide CoA mostly includes findings from lab analyses of a specific batch. For each Acotiamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acotiamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Acotiamide EP), Acotiamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acotiamide USP).
LOOKING FOR A SUPPLIER?